Amgen Delivers On Launch Of First US Humira Rival – At A 55% Discount

Amjevita Biosimilar Version Of Adalimumab Has Six Months With The Market To Itself

Blue paper boat leads several white paper boats
Amgen is leading off US biosimilar competition to Humira • Source: Shutterstock

More from Biosimilars

More from Products